![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1430723-35-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | N-(2',4'-Difluoro-5-(5-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)-[1,1'-biphenyl]-3-yl)cyclopropanesulfonamide REF: IN-DA01LIIWCAS: 1430723-35-5 | % | A consultar | Lun 03 Mar 25 |
![]() | ODM-203 REF: TM-T7611CAS: 1430723-35-5 | 99.85% | 43,00 €~518,00 € | Lun 10 Mar 25 |
![]() | ODM-203 REF: 3D-FHC72335CAS: 1430723-35-5 | Min. 95% | - - - | Producto descatalogado |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
N-(2',4'-Difluoro-5-(5-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)-[1,1'-biphenyl]-3-yl)cyclopropanesulfonamide
CAS:1430723-35-5
Fórmula:
C26H21F2N5O2S
Pureza:
%
Forma y color:
Solid
Peso molecular:
505.5390
Ref: IN-DA01LIIW
1mg | 100,00 € | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
ODM-203
CAS:1430723-35-5
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor …
Fórmula:
C26H21F2N5O2S
Pureza:
99.85%
Forma y color:
Solid
Peso molecular:
505.54
Ref: TM-T7611
2mg | 43,00 € | ||
5mg | 65,00 € | ||
10mg | 96,00 € | ||
25mg | 202,00 € | ||
50mg | 349,00 € | ||
100mg | 518,00 € | ||
1mL*10mM (DMSO) | 72,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
ODM-203
CAS:1430723-35-5
ODM-203 is a growth factor that has been shown to have potent antitumour activity. It …
Fórmula:
C26H21F2N5O2S
Pureza:
Min. 95%
Peso molecular:
505.54 g/mol
Ref: 3D-FHC72335
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |